Načítá se...
Next-generation sequencing in liquid biopsy: cancer screening and early detection
In recent years, the rapid development of next-generation sequencing (NGS) technologies has led to a significant reduction in sequencing cost with improved accuracy. In the area of liquid biopsy, NGS has been applied to sequence circulating tumor DNA (ctDNA). Since ctDNA is the DNA fragments release...
Uloženo v:
| Vydáno v: | Hum Genomics |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BioMed Central
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6669976/ https://ncbi.nlm.nih.gov/pubmed/31370908 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40246-019-0220-8 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|